Share:
Peer-Reviewed Publication
Sci Rep2024;14(1):26454.November 2, 2024Journal Article

Device closure via minimally invasive left intercostal incision in children with perimembranous ventricular septal defect.

Fan Xu1,2, Xiaohong Zeng3, Linfeng Xie1,4, Qiuyu Huang1,4, Yanming Shen1,2, Zhenmei Liao5, Dongshan Liao6,7, Chong-Jiu Fan8
1Department of Cardiovascular Surgery, Fujian Medical University Union Hospital, Xinquan Road No. 29, Fuzhou, 350001, Fujian Province, China.
2Fujian Provincial Center for Cardiovascular Medicine, Fuzhou, 350001, Fujian Province, China.
3Department of Rheumatology, the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, Fujian Province, China.
4Key Laboratory of Cardio-Thoracic Surgery, Fujian Medical University, Fujian Province University, Fuzhou, 350001, Fujian Province, China.
5Ultrasonic Cardiogram Room, Department of Cardiology, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian Province, China.
6Department of Cardiovascular Surgery, Fujian Medical University Union Hospital, Xinquan Road No. 29, Fuzhou, 350001, Fujian Province, China. liao89612@163.com.
7Fujian Provincial Center for Cardiovascular Medicine, Fuzhou, 350001, Fujian Province, China. liao89612@163.com.
8Department of Anesthesiology, Fujian Medical University Union Hospital, Xinquan Road No. 29, Fuzhou, 350001, Fujian Province, China. ajiu163163@163.com.

Abstract

When treating perimembranous ventricular septal defect, median sternotomy leads to unsightly scar, right subaxillary thoracotomy requires cardiopulmonary bypass, and transcatheter device closure constrained by vascular condition. Using small left intercostal incision, we employed transthoracic device closure to get around these issues. During this study, right subaxillary thoracotomy was used for…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.